MetLife, Inc. (MET) Stock Overview
Explore MetLife, Inc.’s financial performance, market position, analyst ratings, and future outlook.
MetLife, Inc. (MET)
Key Financials
Key Financials
Market Cap
63.3B
P/E Ratio
19.08
EPS (TTM)
$9.77
ROE
0.13%
MET Stock Analysis & Investment Overview (NYSE)
Our AI-powered analysis of MetLife, Inc. (NYSE: MET) gives investors deep insight into how the stock performs on the NYSE exchange, its growth potential, and its market positioning. With a Meyka AI Score of B+, MetLife, Inc.'s NYSE-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of MET on the NYSE shows an RSI of 58.36, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $91.37 for the NYSE listing.
Key metrics behind MetLife, Inc.'s NYSE-traded stock include a P/E ratio of 19.08 and a market capitalization of 63.3B. Combined with our AI analysis, these give both institutional and retail investors a clear view of MET on the NYSE.